BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 26487510)

  • 1. The AKR1B1 inhibitor epalrestat suppresses the progression of cervical cancer.
    Ji J; Xu MX; Qian TY; Zhu SZ; Jiang F; Liu ZX; Xu WS; Zhou J; Xiao MB
    Mol Biol Rep; 2020 Aug; 47(8):6091-6103. PubMed ID: 32761301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclopentenone Prostaglandins: Biologically Active Lipid Mediators Targeting Inflammation.
    Lee BR; Paing MH; Sharma-Walia N
    Front Physiol; 2021; 12():640374. PubMed ID: 34335286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspective on the Structural Basis for Human Aldo-Keto Reductase 1B10 Inhibition.
    Ruiz FX; Parés X; Farrés J
    Metabolites; 2021 Dec; 11(12):. PubMed ID: 34940623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability of the Genes Involved in the Cellular Redox Status and Their Implication in Drug Hypersensitivity Reactions.
    Ayuso P; García-Martín E; Agúndez JAG
    Antioxidants (Basel); 2021 Feb; 10(2):. PubMed ID: 33672092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein Lipoxidation: Basic Concepts and Emerging Roles.
    Viedma-Poyatos Á; González-Jiménez P; Langlois O; Company-Marín I; Spickett CM; Pérez-Sala D
    Antioxidants (Basel); 2021 Feb; 10(2):. PubMed ID: 33669164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-Kusunokinin as a Potential Aldose Reductase Inhibitor: Equivalency Observed via AKR1B1 Dynamics Simulation.
    Tanawattanasuntorn T; Thongpanchang T; Rungrotmongkol T; Hanpaibool C; Graidist P; Tipmanee V
    ACS Omega; 2021 Jan; 6(1):606-614. PubMed ID: 33458512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of aldose reductase inhibitors is affected by oxidative stress induced under X-ray irradiation.
    Castellví A; Crespo I; Crosas E; Cámara-Artigas A; Gavira JA; Aranda MAG; Parés X; Farrés J; Juanhuix J
    Sci Rep; 2019 Feb; 9(1):3177. PubMed ID: 30816220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detoxifying Enzymes at the Cross-Roads of Inflammation, Oxidative Stress, and Drug Hypersensitivity: Role of Glutathione Transferase P1-1 and Aldose Reductase.
    Sánchez-Gómez FJ; Díez-Dacal B; García-Martín E; Agúndez JA; Pajares MA; Pérez-Sala D
    Front Pharmacol; 2016; 7():237. PubMed ID: 27540362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGA1-induced apoptosis involves specific activation of H-Ras and N-Ras in cellular endomembranes.
    Anta B; Pérez-Rodríguez A; Castro J; García-Domínguez CA; Ibiza S; Martínez N; Durá LM; Hernández S; Gragera T; Peña-Jiménez D; Yunta M; Zarich N; Crespo P; Serrador JM; Santos E; Muñoz A; Oliva JL; Rojas-Cabañeros JM
    Cell Death Dis; 2016 Jul; 7(7):e2311. PubMed ID: 27468687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders.
    Srivastava SK; Yadav UC; Reddy AB; Saxena A; Tammali R; Shoeb M; Ansari NH; Bhatnagar A; Petrash MJ; Srivastava S; Ramana KV
    Chem Biol Interact; 2011 May; 191(1-3):330-8. PubMed ID: 21354119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Search of Differential Inhibitors of Aldose Reductase.
    Balestri F; Moschini R; Mura U; Cappiello M; Del Corso A
    Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Interactions and Implications of Aldose Reductase Inhibition by PGA1 and Clinically Used Prostaglandins.
    Díez-Dacal B; Sánchez-Gómez FJ; Sánchez-Murcia PA; Milackova I; Zimmerman T; Ballekova J; García-Martín E; Agúndez JA; Gharbi S; Gago F; Stefek M; Pérez-Sala D
    Mol Pharmacol; 2016 Jan; 89(1):42-52. PubMed ID: 26487510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of aldo-keto reductase AKR1B10 as a selective target for modification and inhibition by prostaglandin A(1): implications for antitumoral activity.
    Díez-Dacal B; Gayarre J; Gharbi S; Timms JF; Coderch C; Gago F; Pérez-Sala D
    Cancer Res; 2011 Jun; 71(12):4161-71. PubMed ID: 21507934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of protein targets for covalent modification by the antitumoral and anti-inflammatory prostaglandin PGA1: focus on vimentin.
    Gharbi S; Garzón B; Gayarre J; Timms J; Pérez-Sala D
    J Mass Spectrom; 2007 Nov; 42(11):1474-84. PubMed ID: 17960581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective.
    Renedo M; Gayarre J; García-Domínguez CA; Pérez-Rodríguez A; Prieto A; Cañada FJ; Rojas JM; Pérez-Sala D
    Biochemistry; 2007 Jun; 46(22):6607-16. PubMed ID: 17489560
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.